The Key is Historical Study Data (Lots of It) and Artificial Intelligence
Challenge #2: Patient Scarcity
Join us next week in Frankfurt to hear from Bayer Head of Data Sciences & Analytics Benedikt Egersdoerfer and others to exchange best practices in transforming clinical development.
A key takeaway is the evolution of eConsent.
Yesterday we discussed how researchers are trying to incorporate new biomarker data into studies, which can generate a new set of hurdles for clinical development programs. It's clear that overcoming these challenges starts with integration.